TABLE 1.
The causality of blood lead level and Alzheimer’s disease (AD) risk by two-sample Mendelian randomization (MR) analysis using the data of AD consortium (Kunkle et al., 2019).
| SNP | Position | Effect allele | GWAS of blood lead level |
GWAS of AD |
Model | MR analysis |
Heterogeneity test |
Horizontal pleiotropy |
|||||
| Beta | P-value | Beta | P-value | Beta | P-value | Cochran’s Q | P-value | Intercept | P-value | ||||
| rs76153987 | chr3:9214817 | T | −0.195 | 4 × 10–6 | −0.073 | 0.0266 | |||||||
| IVW | 0.245 | 0.0103 | 2.161 | 0.34 | |||||||||
| rs116864947 | chr7:11705786 | T | −0.431 | 3 × 10–7 | −0.123 | 0.0376 | −0.029 | 0.44 | |||||
| WME | 0.262 | 0.0367 | 0.684 | 0.41 | |||||||||
| rs6462018 | chr7:27519118 | G | −0.084 | 4 × 10–6 | −0.002 | 0.8994 | |||||||